RGPD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.460800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.477400E-01
Normal-vs-Stage2
3.244600E-01
Normal-vs-Stage3
1.876120E-02
Normal-vs-Stage4
9.007800E-01
Stage1-vs-Stage2
5.166200E-01
Stage1-vs-Stage3
5.469800E-02
Stage1-vs-Stage4
4.985000E-01
Stage2-vs-Stage3
8.022300E-02
Stage2-vs-Stage4
2.140200E-01
Stage3-vs-Stage4
7.966400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.812000E-01
Normal-vs-AfricanAmerican
6.387600E-01
Normal-vs-Asian
8.583600E-02
Caucasian-vs-AfricanAmerican
8.237200E-01
Caucasian-vs-Asian
8.003900E-02
AfricanAmerican-vs-Asian
1.753780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.098200E-01
Normal-vs-Female
4.986200E-01
Male-vs-Female
9.367800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.035400E-01
Normal-vs-Age(41-60Yrs)
7.049400E-01
Normal-vs-Age(61-80Yrs)
4.171800E-01
Normal-vs-Age(81-100Yrs)
1.818170E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.853600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.597500E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.567600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.967800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.595400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.653970E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.259800E-02
Normal-vs-Daily Drinker
8.866500E-02
Normal-vs-Weekly Drinker
2.716400E-01
Normal-vs-Occasional Drinker
9.844400E-01
Normal-vs-Social Drinker
8.592600E-01
Non Drinker-vs-Daily Drinker
6.280600E-01
Non Drinker-vs-Weekly Drinker
3.525800E-01
Non Drinker-vs-Occasional Drinker
9.374000E-02
Non Drinker-vs-Social Drinker
6.752300E-02
Daily Drinker-vs-Weekly Drinker
2.368400E-01
Daily Drinker-vs-Occasional Drinker
6.628100E-02
Daily Drinker-vs-Social Drinker
2.830100E-02
Weekly Drinker-vs-Occasional Drinker
2.451000E-01
Weekly Drinker-vs-Social Drinker
2.699400E-01
Occasional Drinker-vs-Social Drinker
7.864800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.694800E-01
Normal-vs-Grade 2
1.016370E-01
Normal-vs-Grade 3
3.851600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.144400E-01
Grade 1-vs-Grade 3
7.158800E-01
Grade 1-vs-Grade 4
2.694800E-01
Grade 2-vs-Grade 3
3.670200E-01
Grade 2-vs-Grade 4
1.016370E-01
Grade 3-vs-Grade 4
3.851600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.849430E-01
Normal-vs-NonDiabetic
4.525800E-01
Diabetic-vs-NonDiabetic
3.839400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.217600E-01
Normal-vs-NoPancreatitis
4.098800E-01
Pancreatitis-vs-NoPancreatitis
8.111400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.664800E-01
Normal-vs-N1
3.625000E-01
N0-vs-N1
9.299200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.474200E-01
Normal-vs-TP53-NonMutant
8.534800E-01
TP53-Mutant-vs-TP53-NonMutant
9.512100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
